EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Cellular senescence in cancer immunology and potential therapeutic strategy

Xiao-Dan Qian, Li-De Tao, Li-Hong Zhang, An-Lai Ji, Lei Wang, Muhammad Mudasar Iqbal, Yi Luo

Frontiers in Oncology · 01.04.2026 · 16

DOI: 10.3389/fonc.2026.1737652 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Oncology, online erschienen am 01.04.2026. Verfasst von Xiao-Dan Qian und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics, Northern Jiangsu People's Hospital, Yangzhou, Jiangsu, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cellular senescence represents a state of stable, often irreversible cell cycle arrest. Unlike apoptosis, senescent cells (SCs) remain metabolically active and engage in robust secretory activity, most notably through the senescence-associated secretory phenotype (SASP). The SASP exerts profound and context-dependent effects on tumor initiation and progression. This review analyzes the dual role of senescent cells in tumor immunity. On one hand, they can exhibit anti-tumorigenic effects through SASP-mediated enhancement of immune surveillance and their inherent high immunogenicity. On the other hand, they can promote tumorigenesis by fostering an immunosuppressive microenvironment, polarizing immune cells via the SASP, and upregulating senescence-associated immune checkpoints (SAICs) to facilitate immune escape. These dual characteristics inform promising therapeutic strategies: first, inducing senescence in tumor cells, and second, selectively eliminating the resulting senescent populations. Notably, systemic senescence induction can cause off-target effects in healthy tissues, underscoring the need for targeted delivery systems. In conclusion, we highlight emerging senescence-targeted immunotherapies as a next-generation approach to strategically harness senescence for cancer control.

Schlagwörter

Stichwörter der Autor:innen

cellular senescenceimmune evasionimmunosuppressiveimmunotherapysenescence-associated secretory phenotype

Autor:innen und Institutionen

  • Department of Paediatrics, Northern Jiangsu People's Hospital, Yangzhou, Jiangsu, China.
  • Department of Hepatobiliary Surgery, The Affiliated Hospital of Yangzhou University, Yangzhou, Jiangsu, China.

Zitieren

APA

Qian, X. D., Tao, L. D., Zhang, L. H., Ji, A. L., Wang, L., Iqbal, M. M., & Luo, Y. (2026). Cellular senescence in cancer immunology and potential therapeutic strategy. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1737652

Vancouver

Qian XD, Tao LD, Zhang LH, Ji AL, Wang L, Iqbal MM, et al. Cellular senescence in cancer immunology and potential therapeutic strategy. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1737652

BibTeX
@article{Qian2026,
  author = {Qian, Xiao-Dan and Tao, Li-De and Zhang, Li-Hong and Ji, An-Lai and Wang, Lei and Iqbal, Muhammad Mudasar and Luo, Yi},
  title = {Cellular senescence in cancer immunology and potential therapeutic strategy},
  journal = {Frontiers in Oncology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fonc.2026.1737652}
}
Kostenlos starten →